Why weren't Healius shares trading on the ASX today?

Healius is raising funds at a deep discount and warned there will be no dividends in FY 2024.

| More on:
A man casually dressed looks to the side in a pensive, thoughtful manner with one hand under his chin, holding a mobile phone in his hand while thinking about something.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Healius Ltd (ASX: HLS) shares were missing from action on the ASX on Monday.

That's because the healthcare company requested a trading halt prior to the market open.

But why were Healius shares suspended from trade? Let's find out.

Why weren't Healius shares trading on the ASX on Monday?

According to the trading halt request, Healius required the halt so it could undertake a capital raising.

It has since released details of the capital raising, revealing that it is seeking $187 million from a fully underwritten accelerated non-renounceable entitlement offer.

The company is raising the funds at $1.20 per new share, which represents a whopping 34.6% discount to where Healius shares last traded on the ASX. This significant discount appears to be a sign that demand for its shares isn't overly strong right now.

Healius revealed that the proceeds from the entitlement offer will be used to reduce its net debt and reset its balance sheet with appropriate gearing.

Gearing update

In addition, the company revealed that its lending syndicate has agreed to waive Healius' gearing covenant for first half of 2024 and temporarily increased the covenant from 3.5 times to 4 times at 30 June 2024.

This waiver is in conjunction with a commitment from Healius to reduce its total bank facilities from $1 billion to $750 million and to reduce its drawn debt by at least $150 million by 30 June 2024.

Following the completion of the entitlement offer, Healius expects to have sufficient financial flexibility and liquidity.

However, this will come at a cost to shareholders in more than one way. As well as dilution from the capital raising, the company revealed that it will not declare or pay any dividends for FY 2024.

Trading update

Healius has had a tough start to the year and has provided guidance that reflects this.

It expects to report underlying EBITDA of $158 million to $161 million and EBIT of $14 million to $17 million for the first half. This compares to EBITDA and EBIT of $176.8 million and $40 million, respectively, during the prior corresponding period.

For FY 2024, underlying EBITDA of $383 million to $393 million and EBIT of $95 million to $105 million is expected by the company. The latter compares to EBIT of $99 million in FY 2023.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Capital Raising

A man sits in deep thought with a pen held to his lips as he ponders his computer screen with a laptop open next to him on his desk in a home office environment.
Real Estate Shares

Goodman share price dips then lifts amid capital raise falling flat

Only $5.1 million was raised in Goodman's $400 million share purchase plan offer for retail investors.

Read more »

A woman sits at her computer with her chin resting on her hand as she contemplates her next potential investment.
Financial Shares

Undercover surging payments company announces $45 million capital raise

It's been a busy time for this payments company.

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Capital Raising

Why did this ASX All Ords defence stock crash 22% today?

Investors seem to be rather furious at this stock.

Read more »

Man with a hand on his head looks at a red stock market chart showing a falling share price.
Capital Raising

Why is the Goodman share price crashing 7% today?

Let's find out what is weighing down this blue chip this morning.

Read more »

A man casually dressed looks to the side in a pensive, thoughtful manner with one hand under his chin, holding a mobile phone in his hand while thinking about something.
Earnings Results

Why are Goodman shares in a trading halt on results day?

What's going on with this blue chip on Wednesday? Let's find out.

Read more »

A man holds his head in his hands, despairing at the bad result he's reading on his computer.
Technology Shares

Why is this ASX All Ords stock crashing 10% on Friday?

This share is having a tough time. What's going on?

Read more »

A man looking at his laptop and thinking.
Capital Raising

Guess the ASX All Ords stock launching a capital raising at a 52-week low

After failing last month, the struggling company is trying again.

Read more »

Shot of a young businesswoman looking stressed out while working in an office.
Healthcare Shares

Why is the Mesoblast share price crashing 9% today?

What is weighing on this high-flying stock on Tuesday? Let's find out.

Read more »